Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
67 hedge funds and large institutions have $113M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 11 closing their positions.
503% more call options, than puts
Call options by funds: $4.1M | Put options by funds: $680K
36% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 11
5% more funds holding
Funds holding: 64 → 67 (+3)
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
58% less capital invested
Capital invested by funds: $268M → $113M (-$154M)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.56M |
| 2 |
BlackRock
New York
|
+$4.97M |
| 3 |
Jennison Associates
New York
|
+$3.27M |
| 4 |
EU
Emory University
Atlanta,
Georgia
|
+$1.96M |
| 5 |
Axa
Paris,
France
|
+$1.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$12M |
| 2 |
DM
Deerfield Management
New York
|
-$4M |
| 3 |
DA
DSC Advisors
Chicago,
Illinois
|
-$3.59M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.52M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2.31M |
FOMX Hedge Fund Activity: Q1 2017 in Review
67 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q1 2017, worth a combined $113M — down 58% from $268M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new FOMX positions and 11 closed out — a net gain of 4 holders — while 19 added to existing stakes and 21 trimmed.
The largest buyer was Great Point Partners, adding an estimated $6.56M. The largest seller was Menora Mivtachim Holdings, cutting an estimated $12M.
- 67 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q1 2017, up from 64 in Q4 2016.
- Funds reported $113M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q1 2017, down 58% quarter-over-quarter.
- 15 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q1 2017 and 11 closed out, a net change of +4 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q1 2017 was Great Point Partners, an estimated $6.56M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q1 2017 was Menora Mivtachim Holdings, an estimated $12M sold.
Based on aggregated 13F filings for Q1 2017.